although
differ
group
coronavirus
sever
acut
respiratori
syndromecoronaviru
sarscov
use
receptor
angiotensin
convert
enzym
ace
entri
host
cell
despit
common
receptor
consequ
entri
differ
sever
respiratori
distress
case
sarscov
frequent
mild
respiratori
infect
use
wholli
recombin
system
investig
abil
viru
receptorbind
protein
spike
protein
bind
solut
cell
surfac
assay
find
protein
weaker
interact
sarscov
protein
particularli
solut
bind
residu
requir
contact
similar
also
confirm
site
lie
residu
loweraffin
interact
might
partli
explain
differ
patholog
consequ
infect
sarscov
sever
acut
respiratori
syndrom
sar
coronavirus
cov
two
new
member
famili
coronavirida
receiv
consider
attent
sinc
recent
discoveri
drosten
et
al
kuiken
et
al
li
et
al
pyrc
et
al
sloot
et
al
van
der
hoek
et
al
infect
sarscov
caus
sever
acut
respiratori
syndrom
high
level
morbid
mortal
drosten
et
al
feng
gao
kuiken
et
al
infect
rare
requir
hospit
despit
commonli
associ
lower
respiratori
tract
infect
croup
van
der
hoek
van
der
hoek
et
al
wu
et
al
virus
use
angiotensin
convert
enzym
ace
viral
receptor
hofmann
et
al
li
et
al
rais
interest
possibl
differ
patholog
part
result
differenti
receptor
engag
virusmedi
downregul
suggest
underli
patholog
sarscov
infect
kuba
et
al
unclear
also
case
follow
engag
cellular
pathway
intern
two
virus
also
appear
differ
sarscov
requir
presenc
lysosom
cystein
proteas
cathepsin
l
infect
suscept
cell
requir
huang
et
al
data
suggest
although
virus
util
receptor
consequ
receptor
bind
differ
although
reason
remain
unclear
use
pseudotyp
solubl
bind
mammalian
cell
hofmann
et
al
show
lead
effici
smediat
entri
bind
appar
lower
sarscov
later
suggest
may
consequ
protein
bind
differ
region
hofmann
et
al
contrast
follow
definit
minimum
receptorbind
domain
rbd
within
residu
li
et
al
show
incub
tag
form
rbd
cell
line
express
number
natur
synthet
variant
indic
contact
residu
critic
bind
sarscov
overlap
li
et
al
bind
site
virus
distinct
activ
site
enzym
guy
et
al
towler
et
al
consist
fact
treatment
cell
potent
inhibitor
effect
srbd
interact
viru
entri
li
et
al
howev
confirm
fulllength
sarscov
appear
bind
cell
effici
sarscov
rbd
less
effici
compet
pseudotyp
entri
competit
sarscovmedi
entri
ic
ng
ml
compar
ng
ml
sarscov
li
et
al
recent
report
suggest
minimum
rbd
lie
residu
express
alon
bind
affin
reach
observ
sarscov
lin
et
al
use
wholli
recombin
system
preclud
involv
cell
surfac
factor
present
mammalian
cell
lectin
eg
dcsign
marzi
et
al
show
solubl
form
sarscov
protein
bind
solubl
vitro
substanti
differ
affin
discrep
bind
maintain
reduc
protein
display
cell
surfac
avid
may
compens
inher
affin
chang
confirm
residu
shown
critic
sarscov
bind
also
abolish
bind
bind
involv
uniqu
aminotermin
sequenc
differ
affin
interact
differ
cov
protein
therefor
independ
assay
format
may
underli
differ
patholog
outcom
infect
investig
cov
protein
bind
unifi
format
produc
solubl
cellbound
version
two
protein
use
baculoviru
express
vector
design
secret
protein
fctag
fusion
protein
chen
et
al
separ
display
insect
cell
surfac
follow
tag
vsv
g
protein
transmembran
tm
domain
chappl
jone
see
supplementari
fig
avail
jgv
onlin
vector
isogen
except
tag
employ
lead
abund
express
target
glycoprotein
cell
supernat
sarscov
protein
subdomain
thereof
fig
addit
produc
secret
form
fuse
green
fluoresc
protein
gfp
provid
ligand
altern
tag
detect
ligand
bind
order
valid
interact
assay
use
produc
two
variant
sarscov
domain
alanin
substitut
arginin
asparagin
known
reduc
affin
sarscov
interact
chakraborti
et
al
addit
introduc
two
alanin
substitut
sequenc
tyrosin
lysin
map
import
interact
sarscov
li
et
al
differenti
tag
mutat
potenti
ligand
assess
interact
cov
protein
elisa
pulldown
flow
cytometri
assay
preliminari
elisa
captur
plate
follow
incub
variou
fctag
form
protein
detect
antihuman
ig
conjug
show
detect
interact
sarscov
interact
either
expect
data
shown
ligand
bind
equal
demonstr
altern
format
captur
follow
antigfp
probe
howev
equival
concentr
protein
interact
deriv
detect
either
assay
format
suggest
affin
interact
solut
substanti
lower
sarscov
supernat
contain
fctag
cov
protein
concentr
spin
dialysi
level
protein
present
normal
quantit
western
blot
equival
amount
fctag
protein
incub
solut
h
u
c
follow
pulldown
fc
compon
protein
conjug
sepharos
bead
recov
content
resolv
sdspage
presenc
cov
protein
gfptag
detect
western
blot
use
antihuman
ig
antigfp
antibodi
respect
observ
sarscov
pull
effect
protein
pull
less
weightforweight
basi
fig
interact
appar
subscript
number
indic
residu
contain
within
fragment
confirm
uniqu
residu
amino
terminu
bind
hofmann
et
al
li
et
al
fig
use
sarscov
minimum
bind
construct
test
rel
pulldown
substitut
residu
sarscov
fail
interact
significantli
reduc
demonstr
bind
pull
doubl
mutant
fig
also
fail
effect
pull
pull
either
doubl
mutant
fig
togeth
data
show
lower
innat
affin
compar
sarscov
confirm
result
li
et
al
show
sarscov
bind
overlap
sequenc
howev
studi
demonstr
role
residu
notic
differ
substitut
resid
lysin
alanin
reduc
abolish
sarscov
bind
effect
abolish
bind
addit
end
point
construct
differ
somewhat
publish
li
et
al
data
reduc
carboxytermin
boundari
rbd
analog
fcfusion
protein
configur
residu
howev
boundari
reduc
far
residu
recent
describ
lin
et
al
affin
interact
less
sarscov
would
explain
inabl
obtain
sound
k
interact
surfac
plasmon
reson
sarscov
affin
supplementari
fig
avail
jgv
onlin
similar
publish
valu
li
et
al
howev
assay
format
fail
record
accur
k
interact
assess
whether
low
affin
might
partli
compens
avid
effect
protein
cluster
viral
surfac
use
protein
domain
express
vsv
g
tm
fusion
insect
cell
surfac
examin
bind
solubl
use
flow
cytometri
insect
cell
express
protein
day
postinfect
pi
express
level
satur
fig
incub
infect
cell
excess
result
twoto
threefold
differ
bind
sarscov
fig
rang
protein
fragment
assess
bind
observ
deriv
except
uniqu
aminotermin
domain
fig
agreement
solut
phase
pulldown
assay
sarscov
decor
insect
cell
fig
pulldown
variou
fctag
protein
incub
mutant
follow
sdspage
blot
probe
antihuman
ig
detect
protein
fc
upper
panel
antigfp
detect
gfp
lower
panel
ligand
wildtyp
sampl
lane
sarscov
sarscov
residu
respect
b
ligand
wildtyp
lane
lane
lane
lane
sampl
pulldown
sarscov
lane
molecular
mass
marker
indic
kda
fig
interact
cov
protein
measur
flow
cytometri
insect
cell
infect
recombin
baculovirus
express
vsv
gtag
form
protein
use
day
pi
incub
either
mutant
direct
comparison
sarscov
equival
incub
wildtyp
b
comparison
differ
fragment
use
wildtyp
c
comparison
sarscov
c
incub
mutant
note
residu
shift
sarscov
appar
incub
mutant
reduc
bind
observ
protein
rel
reduct
bind
parallel
seen
pulldown
assay
neither
protein
bound
mutant
significantli
low
residu
bind
mutant
display
sarscov
bind
display
protein
conclud
multival
present
protein
cell
surfac
retain
differenti
bind
affin
shown
solutionphasebind
sarscov
protein
sarscov
protein
significantli
higher
affin
protein
multival
partli
reduc
factor
differ
densitometri
pulldown
reveal
differ
solut
fig
peak
fluoresc
show
approxim
threefold
differ
cell
surfac
fig
specul
use
receptor
viru
entri
almost
effect
sarscov
consequ
bind
event
downstream
bind
may
differ
consist
rel
level
cell
entri
exhibit
virus
pseudotyp
sarscov
hofmann
et
al
howev
solubl
purifi
rbd
sarscov
rel
weak
competitor
smediat
pseudotyp
viru
entri
li
et
al
addit
confirm
residu
key
sarscov
bind
also
involv
bind
contribut
individu
residu
exemplifi
may
differ
relat
molecular
contact
protein
receptor
describ
sarscov
remain
unknown
li
et
al
despit
identif
residu
critic
contact
lin
et
al
remain
determin
exactli
differ
signal
follow
sarscov
protein
bind
whether
relat
patholog
infect
